| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AEHR | Common Stock | Award | $0 | +82.5K | +14.71% | $0.00 | 643K | Jul 14, 2022 | Direct | F1 |
| transaction | AEHR | Common Stock | Award | $0 | +69K | +10.73% | $0.00 | 712K | Jul 14, 2022 | Direct | F2 |
| transaction | AEHR | Common Stock | Tax liability | -$293K | -36.6K | -5.14% | $8.00* | 676K | Jul 14, 2022 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | This report on Form 4/A is being filed to correct the footnote 1 on form 4 originally filed on July 18, 2022. The correct footnote should state: One-sixteenth (1/16) of the 75,000 of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. One-sixteenth (1/16) of the 7,500 of shares subject to the restricted shares awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. |
| F2 | Represents shares of common stock issued upon vesting of performance-based RSUs. |
| F3 | Represents shares that were withheld to satisfy tax withholding obligations upon vesting of performance-based RSUs described in footnote 2. This does not represent a sale by the Reporting Person. |
| F4 | The amount reported includes shares subject to unvested restricted shares and restricted stock units. |
Ex. 24 - Power of Attorney